Clinical Trials Browser

Phase NA × ferumoxtran-10 × Genitourinary × Clear all

NCT00147238 2012-08-07

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

Phase NA Terminated

10 enrolled 3 charts

Urinary Bladder Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms